Need more information on 3D APT?
Request more information here and we will get in touch with you soon.
Need more information on 3D APT?
Request more information here and we will get in touch with you soon.
In a society where neurological disorders represent a heavy burden, Philips is committed to provide superb diagnostic clarity and treatment guidance for all patients. Today, although MR is the gold standard in neuro oncology imaging, its accuracy in tumor grading and treatment follow up assessment can be further improved.
3D APT (Amide Proton Transfer) is a unique, contrast-free, brain MR imaging method addressing the need for more confident diagnosis in neuro oncology. 3D APT uses the presence of endogenous cellular proteins, to produce an MR signal that directly correlates with cell proliferation, a marker of tumoral activity. 3D APT can support trained medical professionals in differentiating low grade from high grade gliomas and, in differentiating tumor progression from treatment effect1.
It would be impactful to have a sequence like APT, which could assist us in making those decisions with more confidence”
Jeffrey Miller, MD
Pediatric radiologist at Phoenix Children’s Hospital (PCH)
APT was added to about 70 MRI exams of children with brain tumor and we saw some encouraging early results”
John Curran, MD
Radiologist at Phoenix Children’s Hospital (PCH)
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.